P3 Health Partners Faces Delisting Notice
Ticker: PIIIW · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1832511
| Field | Detail |
|---|---|
| Company | P3 Health Partners Inc. (PIIIW) |
| Form Type | 8-K |
| Filed Date | Nov 28, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $2.5 million |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-action
TL;DR
P3 Health Partners might get delisted, stock could tank.
AI Summary
P3 Health Partners Inc. filed an 8-K on November 21, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The company, formerly Foresight Acquisition Corp., is incorporated in Delaware and has its principal executive offices in Henderson, Nevada.
Why It Matters
This filing indicates potential issues with P3 Health Partners' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a severe risk to its operations and shareholder value.
Key Players & Entities
- P3 Health Partners Inc. (company) — Registrant
- Foresight Acquisition Corp. (company) — Former company name
- November 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Henderson, Nevada (location) — Principal executive offices
FAQ
What specific rule or standard has P3 Health Partners Inc. failed to satisfy, leading to the notice of delisting?
The filing does not specify the exact rule or standard that P3 Health Partners Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the notice of delisting or failure to satisfy a continued listing rule or standard issued?
The notice was issued on November 21, 2025, which is the date of the earliest event reported in this 8-K filing.
What was P3 Health Partners Inc. formerly known as?
P3 Health Partners Inc. was formerly known as Foresight Acquisition Corp.
In which state is P3 Health Partners Inc. incorporated?
P3 Health Partners Inc. is incorporated in Delaware.
Where are P3 Health Partners Inc.'s principal executive offices located?
P3 Health Partners Inc.'s principal executive offices are located at 2370 Corporate Circle Suite 300, Henderson, Nevada 89074.
Filing Stats: 665 words · 3 min read · ~2 pages · Grade level 13.7 · Accepted 2025-11-28 13:29:52
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share PIII The Nasdaq Stock Market
- $2.5 million — that the Company maintain a minimum of $2.5 million in stockholders' equity, and that the C
Filing Documents
- piii-20251121.htm (8-K) — 27KB
- piii-20251121_g1.jpg (GRAPHIC) — 201KB
- 0001832511-25-000028.txt ( ) — 647KB
- piii-20251121.xsd (EX-101.SCH) — 2KB
- piii-20251121_def.xml (EX-101.DEF) — 15KB
- piii-20251121_lab.xml (EX-101.LAB) — 26KB
- piii-20251121_pre.xml (EX-101.PRE) — 16KB
- piii-20251121_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 21, 2025, P3 Health Partners Inc. (the "Company") received a letter (the "Letter") from the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"), which notified the Company that it does not presently comply with Nasdaq's Listing Rule 5550(b)(1) (the "Listing Rule"), which requires that the Company maintain a minimum of $2.5 million in stockholders' equity, and that the Company also does not meet the alternatives of market value of listed securities or net income from continuing operations set forth in the Listing Rule. The Letter does not have any immediate effect on the listing of the Company's common stock or warrants on Nasdaq, and the Company has 45 calendar days to submit a plan to regain compliance. If the Company's plan is accepted, the Staff may grant an extension of up to 180 calendar days from November 21, 2025 to evidence compliance. After review of the plan of compliance, the Staff will provide written notification to the Company as to whether it accepts the plan, and if the Staff does not accept the plan, the Company would then be entitled to appeal the Staff's determination to the Nasdaq Hearings Panel. There can be no assurance that any such appeal would be successful. The Company intends to submit its plan to remediate the listing qualification deficiency within the required timeframe and is actively pursuing the steps necessary to restore compliance. Management firmly believes in the long-term value-creation opportunity of the business and remains committed to executing against the initiatives that support sustainable growth and achieving profitability.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. P3 Health Partners Inc. Date: November 28, 2025 By: /s/ Leif Pedersen Leif Pedersen Chief Financial Officer